Technical Program Manager at Epia Neuro (Alameda, CA)

Epia Neuro· Alameda, CA· $110k–$155k·3d ago

Role details

Salary

$110k–$155k

Work type

Onsite

Employment

Full-Time

Job description

ABOUT US

Epia Neuro is a neural technology company developing intent-driven systems designed to restore function and independence for people living with neurological conditions. Its platform integrates implantable neural interfaces, adaptive algorithms, and assistive devices to translate neural intent into real-world action. The company’s initial focus is stroke-related motor impairment, with expansion in cognitive decline and other neurological disorders, focusing on long-term solutions for the growing aging population.

THE ROLE

The software behind our platform spans embedded firmware, patient- and clinician-facing device applications, and cloud infrastructure for model training and data management. We are looking for a Technical Program Manager to own program management across these work streams: building integrated schedules, tracking cross-team dependencies, running our planning cadence, and keeping software deliverables on track as we drive toward clinical milestones.

KEY RESPONSIBILITIES

Own program planning and execution across our software and firmware workstreams.
Build and maintain integrated schedules across teams; identify, track, and escalate cross-team dependencies and risks before they become slips.
Run our planning and delivery cadence (Jira/Confluence): sprint planning support, milestone tracking, dashboards, and clear status reporting to engineering and company leadership.
Coordinate regulated software documentation with our Quality and Regulatory teams (including IEC 62304 lifecycle deliverables, cybersecurity documentation, reviews, traceability) so compliance work is scheduled and resourced appropriately. Quality owns the process; you make sure engineering delivers into it.
Support planning inputs for regulatory submissions.
Interface with hardware and research program management counterparts to keep software commitments aligned with device-level and study-level plans.

REQUIRED QUALIFICATIONS

3–5+ years of technical program or project management experience supporting software, firmware, or embedded systems teams.
Demonstrated ability to run cross-functional planning: dependency mapping, schedule ownership, risk tracking, and escalation across multiple engineering teams.
Fluency with Jira and Confluence (or equivalent) as working tools.
Strong written communication: you can turn a messy cross-team status into a one-page summary an executive can act on.
Comfort with ambiguity: we are a ~50-person startup and processes are being built as we go. You want to build them, not just inherit them.

PREFERRED QUALIFICATIONS

Experience in regulated medical device software development: IEC 62304, design controls, design history file deliverables, or equivalent regulated-industry experience (aerospace, automotive functional safety).
Program management for embedded/firmware development, including hardware-dependent scheduling.
Exposure to medical device cybersecurity documentation (FDA premarket cybersecurity guidance, SBOM management).
Experience supporting FDA submissions (IDE, PMA, 510(k)).
Familiarity with ML development workflows or cloud infrastructure programs.

HOW WE WORK

We are intentional. We prioritize and are thoughtful about how we use others’ time.
We care for others. We prioritize safety both for patients and one another.
We own outcomes, not just tasks. Our work demands the highest standards because it impacts real patients and real lives.
Humility is a strength. We are honest about what we know and what we don’t know. Getting it right matters more than being right.

Benefits

Full-time employees are eligible for the following benefits listed below.

Competitive base salary with equity
100% of healthcare coverage for you and your dependents
Generous vacation policy
Paid parental leave
Work from our beautiful waterfront office in Alameda, CA, with access to collaborative spaces and labs

Why work at Epia Neuro

Mission‑Driven: Employees directly contribute to restoring independence for stroke survivors and people with neurological conditions (“If you want your work to restore independence for millions of people, we want to hear from you.”)
Cutting‑Edge Technology: Work on the frontier of medical BCI, combining implantable hardware, adaptive AI, and real‑time neural decoding.
Early‑Stage Culture: As a recently launched startup (~24 employees), you’ll have outsized impact on product design, clinical strategy, and company trajectory.
Multidisciplinary Team: Composed of engineers, neuroscientists, and operations leaders from iota Biosciences, UC Berkeley, Harvard, and industry.
Work Style: Likely in‑office in Alameda, CA (with a small presence in Canada); no formal remote/hybrid policy announced yet.
Active Hiring: Open roles include Staff/Principal Electrical Systems Engineer, Analog Mixed‑Signal Design Engineer, and other technical positions (see careers page).

About Epia Neuro

Company Overview

One-liner: Epia Neuro is developing a minimally invasive, implantable brain-computer interface system that translates neural intent into real-world action, starting with stroke recovery and expanding to cognitive decline and other neurological disorders.
Entity Type: Private (stealth-stage startup – officially launched April 2026; no funding round disclosed)
Headquarters: Alameda, California, United States
Founded: 2026 (official launch); development began approximately 2021
Founders: Michel Maharbiz, Ph.D. (CEO) and Gil Mandelbaum, Ph.D. (CTO & Science Officer)

Core Business

Primary industry: Medical Equipment Manufacturing / Neurotechnology (Brain-Computer Interfaces)
Target customers: B2B – hospitals, neurosurgery departments, rehabilitation clinics; B2C – stroke survivors and individuals with movement or cognitive impairments
Mission statement: “To address the gap between intent and action” – building neurotechnology that gives back the freedom to move and think

Products & Services

Implantable Brain Interface: A proprietary neural interface that captures signals without piercing the dura. Designed for sub-hour implantation by any neurosurgeon. Supports both sensing (reading neural intent) and stimulation (closed-loop therapy). Rechargeable non-invasively via headset and built with a cradle system for future upgrades without additional invasive surgery.
Decoder System / Closed-Loop Intelligence: Adaptive algorithms that interpret neural signals in real time and adjust stimulation parameters continuously, building a personalized “longitudinal map” of each patient’s neural activity.
Wearable Grip Assist: A lightweight, daily-use motor prosthetic that helps stroke survivors grasp, hold, and release objects. Developed with input from survivors, advocates, and clinicians.
Platform Expansion: The stroke therapy acts as a proof-of-concept for treating epilepsy, Parkinson’s disease, cognitive decline, and other neurological conditions through combined sensing and deep brain stimulation.

Market Standing

Valuation: Not publicly available (company is pre‑revenue and privately held)
Key Metric: Total funding – not publicly disclosed (company is “totally independent” according to Inside BCI, with no disclosed investors)
Notable Investors/Partners: Institutional advisors include Mass General Hospital, Lenox Hill Hospital (first‑in‑human trial site), Beth Israel Deaconess Medical Center, and Harvard Medical School. No formal investor list has been released.
Growth Signals: Official launch April 2026; plans for first‑in‑human system demonstrations at Lenox Hill Hospital (New York) later in 2026; headcount of 24 employees (as of mid‑2026) with active hiring across engineering, electrical systems, and clinical roles; increasing LinkedIn follower base (1,459) and strong social engagement on launch posts.

Competitive Advantages

Minimally Invasive: Implant sits entirely within the skull, no breach of dura – reduces surgical risk compared to penetrating cortical BCIs.
Quick Procedure & Scalability: Designed for sub‑hour implantation by any neurosurgeon, facilitating broad clinical adoption.
Upgradable & Long‑Life: Cradle system allows device upgrades without additional surgery. Rechargeable headset eliminates the need for battery‑replacement surgeries.
Closed‑Loop Read/Write: Both senses neural signals and delivers stimulation, enabling adaptive, real‑time therapy (beyond read‑only BCIs).
Platform Approach: Stroke motor recovery is the entry point; the same hardware/software stack can address epilepsy, Parkinson’s, and cognitive decline, creating a large addressable market (estimated >$5B US opportunity for stroke alone).

Strategic Focus

Near‑term: Complete first‑in‑human demos, prepare for regulatory submissions (FDA), and scale the engineering team.
Medium‑term: Leverage stroke clinical data to build evidence for cognitive decline and other indications; broaden the implant’s deep brain stimulation capabilities.
Long‑term: Become a standard‑of‑care neural interface platform for a wide range of neurological disorders, with an emphasis on “widely accessible” neurotechnology.

Sources